Alpha-fetoprotein (AFP) has long served as the primary biomarker for HCC patients, playing a crucial role in early HCC screening, often in conjunction with imaging modalities like ultrasound or computed tomography [8]. This evidence concerns the gene AFP and hepatocellular carcinoma.